Free Trial

Tarsus Pharmaceuticals (TARS) Short Interest Ratio & Short Volume

$26.50
-0.54 (-2.00%)
(As of 11:58 AM ET)

Tarsus Pharmaceuticals Short Interest Data

Current Short Interest
8,460,000 shares
Previous Short Interest
7,960,000 shares
Change Vs. Previous Month
+6.28%
Dollar Volume Sold Short
$229.94 million
Short Interest Ratio
13.5 Days to Cover
Last Record Date
June 30, 2024
Outstanding Shares
37,780,000 shares
Percentage of Shares Shorted
22.39%
Today's Trading Volume
233,106 shares
Average Trading Volume
691,614 shares
Today's Volume Vs. Average
34%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Tarsus Pharmaceuticals ?

Sign up to receive the latest short interest report for Tarsus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TARS Short Interest Over Time

TARS Days to Cover Over Time

TARS Percentage of Float Shorted Over Time

Tarsus Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/20248,460,000 shares $229.94 million +6.3%N/A13.5 $27.18
6/15/20247,960,000 shares $246.60 million +6.4%N/A13.7 $30.98
5/31/20247,480,000 shares $246.54 million +0.1%N/A13.4 $32.96
5/15/20247,470,000 shares $287.60 million -2.5%N/A11.1 $38.50
4/30/20247,660,000 shares $240.75 million -3.0%N/A10.7 $31.43
4/15/20247,900,000 shares $276.03 million +0.6%N/A10.7 $34.94
3/31/20247,850,000 shares $285.35 million +9.0%N/A10.1 $36.35
3/15/20247,200,000 shares $227.38 million +19.4%N/A9.3 $31.58
2/29/20246,030,000 shares $230.47 million +6.5%N/A7.5 $38.22
2/15/20245,660,000 shares $178.57 million +4.2%N/A7.7 $31.55
1/31/20245,430,000 shares $147.91 million +8.2%N/A7.7 $27.24
1/15/20245,020,000 shares $110.94 million +0.4%N/A7.9 $22.10
12/31/20235,000,000 shares $101.25 million +1.8%N/A8.2 $20.25
12/15/20234,910,000 shares $93.54 million +10.3%N/A8.3 $19.05
11/30/20234,450,000 shares $73.56 million -0.2%N/A8.1 $16.53
11/15/20234,460,000 shares $79.97 million +6.2%N/A9.2 $17.93
10/31/20234,200,000 shares $59.81 million +5.0%N/A10.1 $14.24
10/15/20234,000,000 shares $51.92 million -19.4%N/A7.6 $12.98
9/30/20234,960,000 shares $88.14 million +13.0%N/A10.2 $17.77
9/15/20234,390,000 shares $70.85 million -2.7%N/A10.1 $16.14
8/31/20234,510,000 shares $78.97 million +0.7%N/A10.8 $17.51
8/15/20234,480,000 shares $76.16 million +17.9%N/A11.3 $17.00
7/31/20233,800,000 shares $83.64 million +65.9%N/A9.9 $22.01
7/15/20232,290,000 shares $40.42 million +2.2%13.0%10.7 $17.65
6/30/20232,240,000 shares $40.48 million +42.7%11.4%11 $18.07
6/15/20231,570,000 shares $29.23 million +72.6%8.0%7.8 $18.62
5/31/2023909,800 shares $15.24 million +6.8%4.7%5.5 $16.75
5/15/2023852,000 shares $14.11 million -11.3%4.4%6.2 $16.56
4/30/2023960,800 shares $14.34 million +0.2%5.0%8.7 $14.92
4/15/2023959,400 shares $11.10 million -3.3%5.0%9.3 $11.57
3/31/2023991,600 shares $12.46 million -4.7%5.2%12 $12.57
3/15/20231,040,000 shares $14.29 million +4.3%5.4%14.2 $13.74
2/28/2023996,700 shares $15.44 million +1.1%5.4%12 $15.49
2/15/2023985,900 shares $15.12 million +1.8%5.3%11.2 $15.34
1/31/2023968,800 shares $15.27 million -6.9%5.1%9.9 $15.76
1/15/20231,040,000 shares $15.12 million No Change5.5%9.7 $14.54
12/30/20221,040,000 shares $15.25 million +19.0%6.1%10.9 $14.66
12/15/2022874,300 shares $12.91 million -28.9%5.1%9.1 $14.77
11/30/20221,230,000 shares $20.68 million -3.2%7.2%12.8 $16.81
11/15/20221,270,000 shares $22.61 million -14.8%7.4%13.7 $17.80
Trump Warns Gov. Can Confiscate Your Money. CBDC's give Gov. absolute (Ad)

Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.

This means you must act NOW before it's too late.
10/31/20221,490,000 shares $27.45 million -0.7%8.9%16.6 $18.42
10/15/20221,500,000 shares $25.47 million +0.7%9.0%17.5 $16.98
9/30/20221,490,000 shares $25.51 million +19.2%8.9%17.4 $17.12
9/15/20221,250,000 shares $19.96 million No Change7.5%11.1 $15.97
8/31/20221,250,000 shares $19.23 million No Change7.5%10.6 $15.38
8/15/20221,250,000 shares $22.99 million -1.6%7.5%8.6 $18.39
7/31/20221,270,000 shares $19.08 million -3.8%7.7%6.9 $15.02
7/15/20221,320,000 shares $19.34 million +8.2%8.0%5.6 $14.65
6/30/20221,220,000 shares $17.81 million +91.4%7.4%5.2 $14.60
6/15/2022637,400 shares $8.34 million +45.9%3.9%2.8 $13.09
5/31/2022437,000 shares $6.01 million +13.0%2.6%2.4 $13.75
5/15/2022386,800 shares $5.08 million -32.2%2.3%2.6 $13.13
4/30/2022570,200 shares $10.44 million -3.0%5.9%5.1 $18.31
4/15/2022587,800 shares $10.80 million +7.3%6.1%14 $18.38
3/31/2022548,000 shares $9.22 million +35.4%5.7%14.2 $16.82
3/15/2022404,600 shares $7.17 million +4.7%4.2%11.4 $17.71
2/28/2022386,400 shares $6.81 million +10.0%4.0%13.2 $17.63
2/15/2022351,200 shares $5.62 million +6.3%3.6%11.9 $16.00
1/31/2022330,300 shares $6.63 million +2.3%3.4%11.6 $20.07
1/15/2022322,900 shares $6.70 million -0.7%3.3%12.2 $20.75
12/31/2021325,200 shares $7.32 million 0.0%3.4%10.9 $22.50
12/15/2021325,300 shares $8.57 million +2.7%3.4%10.9 $26.34
11/30/2021316,700 shares $8.42 million +1.3%3.3%10.5 $26.60
11/15/2021312,600 shares $7.99 million -3.3%3.3%10.1 $25.56
10/29/2021323,100 shares $8.97 million -2.3%3.5%11.8 $27.76
10/15/2021330,800 shares $9.43 million +0.6%3.5%11 $28.52
9/30/2021329,000 shares $7.09 million +0.2%3.5%11.9 $21.55
9/15/2021328,400 shares $7.16 million +7.5%3.5%9.3 $21.81
8/31/2021305,400 shares $8.09 million -1.7%3.3%5.6 $26.50
8/13/2021310,800 shares $8.07 million -2.4%3.3%5.3 $25.98
7/30/2021318,500 shares $7.19 million -2.7%3.6%5 $22.57
7/15/2021327,200 shares $8.43 million +3.1%3.7%4.7 $25.76
6/30/2021317,500 shares $9.20 million +12.8%3.6%4.5 $28.98
6/15/2021281,400 shares $9.92 million -10.4%3.3%4.2 $35.26
5/28/2021314,000 shares $10.46 million -15.4%3.7%6.6 $33.32
5/14/2021371,100 shares $10.99 million -3.3%4.3%8.3 $29.62
4/30/2021383,600 shares $11.58 million +0.1%4.5%9.1 $30.20
4/15/2021383,400 shares $11.51 million -5.6%4.5%11.5 $30.01
3/31/2021406,300 shares $11.50 million +3.2%4.8%11.1 $28.30
3/15/2021393,800 shares $13.19 million +6.6%4.7%5.2 $33.50
2/26/2021369,400 shares $13.87 million +5.9%4.4%4.2 $37.56
2/12/2021348,800 shares $12.82 million +34.1%4.2%3.8 $36.76
1/29/2021260,200 shares $10.13 million +2.9%3.1%2.8 $38.92
1/15/2021253,000 shares $11.11 million No Change3.0%2.5 $43.91

TARS Short Interest - Frequently Asked Questions

What is Tarsus Pharmaceuticals' current short interest?

Short interest is the volume of Tarsus Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 8,460,000 shares of TARS short. Learn More on Tarsus Pharmaceuticals' current short interest.

What is a good short interest ratio for Tarsus Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TARS shares currently have a short interest ratio of 14.0. Learn More on Tarsus Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Tarsus Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Tarsus Pharmaceuticals: StemPoint Capital LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Tarsus Pharmaceuticals' short interest increasing or decreasing?

Tarsus Pharmaceuticals saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 8,460,000 shares, an increase of 6.3% from the previous total of 7,960,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Tarsus Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Tarsus Pharmaceuticals: Cabaletta Bio, Inc. (14.87%), Fusion Pharmaceuticals Inc. (3.60%), Harpoon Therapeutics, Inc. (4.31%), MeiraGTx Holdings plc (2.25%), Arcellx, Inc. (11.89%), Denali Therapeutics Inc. (6.34%), Twist Bioscience Co. (16.43%), SpringWorks Therapeutics, Inc. (14.06%), ADMA Biologics, Inc. (3.14%), Apogee Therapeutics, Inc. (21.44%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.71 billion), TC Energy Co. ($2.95 billion), Moderna, Inc. ($2.63 billion), Royal Caribbean Cruises Ltd. ($2.53 billion), Paychex, Inc. ($2.03 billion), Cencora, Inc. ($2.03 billion), Tractor Supply ($1.91 billion), Rivian Automotive, Inc. ($1.78 billion), Chesapeake Energy Co. ($1.50 billion), and United Therapeutics Co. ($1.40 billion). View all of the most shorted stocks.

What does it mean to sell short Tarsus Pharmaceuticals stock?

Short selling TARS is an investing strategy that aims to generate trading profit from Tarsus Pharmaceuticals as its price is falling. TARS shares are trading down $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Tarsus Pharmaceuticals?

A short squeeze for Tarsus Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TARS, which in turn drives the price of the stock up even further.

How often is Tarsus Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TARS, twice per month. The most recent reporting period available is June, 30 2024.



This page (NASDAQ:TARS) was last updated on 7/22/2024 by MarketBeat.com Staff

From Our Partners